Oramed Pharmaceuticals Inc. (ORMP.OB) Appoints New Chief Operating Officer and VP of Business Development
4/16/2013 7:41:02 AM
JERUSALEM, April 16, 2013 /PRNewswire/ --
Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, today announced a key addition to its executive leadership team with the appointment of Joshua Hexter as Chief Operating Officer and Vice President of Business Development.
comments powered by